Skip to content Skip to footer

Adoption of Ondine Biomedical’s Steriwave Technology in Canadian Hospitals Marks a Major Step in Infection Prevention

Ondine Biomedical’s cutting-edge Steriwave technology is set to redefine infection control in Canadian hospitals. A discussion between Nicolas Loebel, President and Chief Technology Officer of Ondine Biomedical, and Steve Darling from Proactive has revealed that the Steriwave technology has been implemented at the Queen Elizabeth II Health Sciences Centre in Halifax, marking a significant advancement for infection prevention in the field of orthopedic surgery.

The Queen Elizabeth II Health Sciences Centre, which is affiliated with Dalhousie University, has integrated the Steriwave as an infection prevention method for orthopedic surgeries, spotlighting the central role of innovations in combating healthcare-associated infections effectively. Designed meticulously to curb post-surgical infections, Steriwave adeptly assuages a major worry in healthcare architecture. Research underlines Steriwave’s potential to ward off extensively drug-resistant microbes (XDR), making it a formidable tool in the battle against antimicrobial resistance. Ondine’s technology eradicates these microbes efficiently, thereby erecting a robust shield against antimicrobial resistance.

As healthcare institutions across the globe confront the escalating concern of antimicrobial resistance, the deployment of Steriwave becomes significantly imperative. The proliferation of drug-resistant pathogens escalates risk factors, consequently emphasizing the importance of infection control and monitoring in healthcare environments. In a testament to its efficacy, Steriwave has already been embraced by hospitals throughout Canada. Prominent establishments such as Vancouver General Hospital, the University of British Columbia, Ottawa hospitals, and the Montreal Heart Institute have integrated Steriwave into their systems.

The widespread acceptance highlights not only the effectiveness of the technology but also an emerging acknowledgment of its critical role in ameliorating healthcare-associated infections. Alarming statistics indicate that one in nine hospital patients in Canada has to grapple with a healthcare-associated infection, leading to approximately 12,000 deaths per year. Infections resistant to antibiotics contribute significantly to this alarming mortality rate.

Source: https://www.investorsobserver.com/news/qm-pr/5114926790841354

Sign Up to Our Newsletter

Be the first to know the latest updates

[yikes-mailchimp form="1"]